Dolby Laboratories (DLB) Tops Q2 EPS by 16c; Guides Q3 Above Views

Dolby Laboratories (NYSE: DLB) reported Q2 EPS of $0.63, $0.16 better than the analyst estimate of $0.47. Revenue for the quarter came in at $267.5 million versus the consensus estimate of $275.81 million.

GUIDANCE:

Dolby Laboratories sees Q3 2017 EPS of $0.75-$0.81, versus the consensus of $0.64. Dolby Laboratories sees Q3 2017 revenue of $290-305 million, versus the consensus of $293.3 million.

For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13
• Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c